Abstract
Increasing drug resistance among bacteria, fungi and other pathogenic microbes and the remarkable increase in the incidence of fungal infections like dermatomycoses in the world population underscore our inadequacy to deal with them. Thus there is an urgent need to search chemically novel, natural, renewable and safe anti-microbial substances that can offer opportunity for innovation of new drugs to combat the widespread dermatomycoses. Six fungal endophytic strains (Scytalidium sp. MCPL AzF 023, Pestalotiopsis sp. MCPL AzB 153, Colletotrichum sp. MCPL AzR 249, Alternaria sp. MCPL AzL 198, Nigrospora sp. MCPL AzS 076, and Chloridium sp. MCPL AzR 142) from Azadirachta indica A Juss were screened and evaluated their efficacy against dermatophytes Trichophyton and Microsporum. The susceptibility test was performed by whole plate diffusion method. The EtOAc extracted Scytalidium, Chloroform extracted Nigrospora, Colletotrichum, and Alternaria, ethyl ether extracted Nigrospora in particular significantly reduced the growth of dermatophytes. The MIC ranged from 125-400 μg ml-1 for Trichophyton and 200-350 μg ml-1 for Microsporum while the MFC ranged from 230 to 425 μg ml-1. The chloroform, EtOAc, and ethyl ether were the solvents that might dissolve major active fractions of Pestalotiopsis, Scytalidium and Chloridium. The growth patterns of dermatophytes were also significantly distorted at concentration of 100 μg ml-1 (below MIC), which is statistically significant with reference to untreated fungi. In this study, we recovered bioactive fractions that might be chemically novel and effective against dermatophytes particularly and on other human and plant pathogens in general. Thus we might anticipate some new bioactive compounds to design new effective drugs against dermatomycoses initially.
Current Bioactive Compounds
Title: Selection of Natural Strains of Fungal Endophytes from Azadirachta indica A. Juss, with Anti-Microbial Activity Against Dermatophytes
Volume: 4 Issue: 1
Author(s): V. C. Verma, S. K. Gond, Ashish Mishra, A. Kumar and R. N. Kharwar
Affiliation:
Abstract: Increasing drug resistance among bacteria, fungi and other pathogenic microbes and the remarkable increase in the incidence of fungal infections like dermatomycoses in the world population underscore our inadequacy to deal with them. Thus there is an urgent need to search chemically novel, natural, renewable and safe anti-microbial substances that can offer opportunity for innovation of new drugs to combat the widespread dermatomycoses. Six fungal endophytic strains (Scytalidium sp. MCPL AzF 023, Pestalotiopsis sp. MCPL AzB 153, Colletotrichum sp. MCPL AzR 249, Alternaria sp. MCPL AzL 198, Nigrospora sp. MCPL AzS 076, and Chloridium sp. MCPL AzR 142) from Azadirachta indica A Juss were screened and evaluated their efficacy against dermatophytes Trichophyton and Microsporum. The susceptibility test was performed by whole plate diffusion method. The EtOAc extracted Scytalidium, Chloroform extracted Nigrospora, Colletotrichum, and Alternaria, ethyl ether extracted Nigrospora in particular significantly reduced the growth of dermatophytes. The MIC ranged from 125-400 μg ml-1 for Trichophyton and 200-350 μg ml-1 for Microsporum while the MFC ranged from 230 to 425 μg ml-1. The chloroform, EtOAc, and ethyl ether were the solvents that might dissolve major active fractions of Pestalotiopsis, Scytalidium and Chloridium. The growth patterns of dermatophytes were also significantly distorted at concentration of 100 μg ml-1 (below MIC), which is statistically significant with reference to untreated fungi. In this study, we recovered bioactive fractions that might be chemically novel and effective against dermatophytes particularly and on other human and plant pathogens in general. Thus we might anticipate some new bioactive compounds to design new effective drugs against dermatomycoses initially.
Export Options
About this article
Cite this article as:
Verma C. V., Gond K. S., Mishra Ashish, Kumar A. and Kharwar N. R., Selection of Natural Strains of Fungal Endophytes from Azadirachta indica A. Juss, with Anti-Microbial Activity Against Dermatophytes, Current Bioactive Compounds 2008; 4 (1) . https://dx.doi.org/10.2174/157340708784533401
DOI https://dx.doi.org/10.2174/157340708784533401 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Deep Learning in the Quest for Compound Nomination for Fighting COVID-19
Current Medicinal Chemistry The Role of Cytokines in Pharmacological Modulation of Hepatic Ischemia/Reperfusion Injury
Current Pharmaceutical Design Non Steroidal Anti Inflammatory Drugs As Gatekeepers Of Colon Carcinoma Highlight New Scenarios Beyond Cyclooxygenases Inhibition
Current Cancer Drug Targets Pharmacological Inhibition of Voltage-gated Ca<sup>2+</sup> Channels for Chronic Pain Relief
Current Neuropharmacology Animal Toxins Acting on Voltage-Gated Potassium Channels
Current Pharmaceutical Design Nitric Oxide and Teratogenesis: An Update
Current Pharmaceutical Design The Development of Cytokine Receptor Antagonists as Potential Therapeutic Agents for the Myeloproliferative Disorders
Current Pharmaceutical Design Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?
Current Pharmaceutical Design A Phosphoproteomics Approach to Identify Candidate Kinase Inhibitor Pathway Targets in Lymphoma-Like Primary Cell Lines
Current Drug Discovery Technologies Protective Mechanism of Lignans from Phyllanthus amarus Against Galactosamine/ Lipopolysaccharide-Induced Hepatitis: An In-Vivo and In-Silico Studies
Current Topics in Medicinal Chemistry Oleanolic Acid Derived from Plants: Synthesis and Pharmacological Properties of A-ring Modified Derivatives
Letters in Drug Design & Discovery Effect of Intestinal Flora Clearance on Liver Proteomics in Mice
Current Proteomics The Nervous System as a Critical Regulator of Immune Responses Underlying Allergy
Current Pharmaceutical Design Antioxidant Therapy in Diabetic Complications: What is New?
Current Vascular Pharmacology Therapeutical Approaches of Vasoactive Intestinal Peptide as a Pleiotropic Immunomodulator
Current Pharmaceutical Design VEGF Inhibitors in Metastatic Renal Cell Carcinoma: Current Therapies and Future Perspectives
Current Clinical Pharmacology Once-a-Day (QD) vs Twice-Daily (BID) Nevirapine as Simplification in PITreated Patients After 2 mos. of BID Induction
Current HIV Research U1 snRNP Control of 3´-End Processing and the Therapeutic Application of U1 Inhibition Combined with RNA Interference
Current Molecular Medicine Targeting Tumor Angiogenesis in Gastrointestinal Malignancies
Current Angiogenesis (Discontinued) Neuropsychological Effects of Mercury Exposure Among Dentists in Monastir City
Recent Patents on Inflammation & Allergy Drug Discovery